Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
President Trump took credit Tuesday for “the safest year on record” for U.S. air travel, touting zero deaths in 2017. But there actually haven’t been any deaths on a U.S. passenger airline in nearly nine years.
Still, the president took credit for the safety record in a tweet.
“Since taking office I have been very strict on Commercial Aviation. Good news....More>>>
The European Central Bank still has a way to go before inflation is on track toward its goal, so policy will need to remain patient and persistent, Executive Board member Peter Praet said on Monday.
Praet, who presents policy proposals at Governing Council meetings in his role as chief economist, said the ECB is monitoring three criteria as it gauges when it can start withdrawing stimulus.....More>>>
The Florida citrus industry was already in big trouble even before Hurricane Irma started closing in. Now experts are worried that the storm could be the final straw that tips many growers into bankruptcy.
The problem until now has not been storms but a disease, known as citrus greening. It’s spread by an insect, and leaves the fruit green, bitter and unusable. As a result, Florida....More>>>
Gold doesn't trade in a vacuum. Markets are connected. What happens in one often affects others. So if you want to understand what's happening with gold, you need to know what's going on in the markets that affect gold. And while lots of traders focus only on the short term, it's important to have a big-picture view, too. The big picture shows you the long-term....More>>>
Xbiotech (NASDAQ:XBIT) has presented the abstract of its European Phase III trial of Xilonix to treat patients with metastatic colorectal cancer (mCRC) refractory to standard treatment at the ESMO GI (European Society for Medical Oncology) 2016, early July. The abstract has shown a 76% relative increase in clinical response rate (CRR), associated....More>>>
Welcome to the latest issue of the PRO Weekly Digest. Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users, we publish highlights from our PRO coverage as well as feature interviews and other notable goings-on with SA PRO. Comment below or email us at pro-editors at seekingalpha.com to let us know what you think. Find past editions here.
In our last article, we noted that the middle market for privately held businesses in the United States has about 350,000 firms. Of those, only about 20% are “ready for sale.” And, we mentioned that there are consultants who assist business owners prepare their companies for sale. Just to be clear, these are value enhancement consultants as opposed to investment....More>>>
This is the inaugural article within a series on German Dividend Champions. These are great dividend investments in German stocks which are currently undervalued and offer significant upside potential. Compared to US stocks like PG or JNJ even the German heavyweights have less impressive and long-reaching dividend track records. That’s why I regularly will only refer to historic data beginning....More>>>
MorphoSys AG (MOR) is a recent addition to the Nasdaq, having raked in close to $208 million in their April IPO when 2,075,000 new ordinary shares in the form of 8,300,000 American Depositary Shares were priced at $25.04 per ADS.
The fact that they were able to raise more than the origina
Spotting certain demographic, technological, or cultural shifts early can be a great way to boost your investment returns. The only constant is change, as the saying goes, and being able to spot those moves and invest accordingly is one way that forward-looking investors can take advantage of tho
Transocean (NYSE:RIG) is one of the best offshore drillers with a record backlog of about ~$12.4 billion as of 05/2/2018 - not including options that could add over $8 billion - after the acquisition of Songa Offshore.
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic st